Roivant Sciences Ltd. (ROIV)
Roivant Sciences Ltd. (ROIV) is a Healthcare stock tracked by StreetAlpha. ROIV reports earnings on Mon, Nov 9, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (6 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in ROIV, 100% of them bullish and 0% bearish. In the past 30 days there were 4 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 17 | Stifel | Initiated | Buy | — |
| Sep 9 | TD Cowen | Target raised | Buy | — |
| Sep 9 | Guggenheim | Target raised | Buy | — |
| Sep 8 | HC Wainwright & Co. | Target raised | Buy | — |
| Sep 8 | Jefferies | Maintained | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ROIV is in one of them and how their past ROIV trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ROIV in an article yet. Here's the latest on the wider market.
ROIV Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Lisa McClainR · MI | Sell | $1K – $15K | Oct 31, 2025 | Nov 21, 2025 | 21 d |
| Lisa McClainR · MI | Buy | $1K – $15K | Oct 30, 2025 | Nov 21, 2025 | 22 d |
| Lisa McClainR · MI | Sell | $1K – $15K | Oct 30, 2025 | Nov 21, 2025 | 22 d |
| Lisa McClainR · MI | Buy | $1K – $15K | Jun 17, 2025 | Aug 13, 2025 | 57 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.